Molecular and cellular characterization of mouse calvarial osteoblasts derived from neural crest and paraxial mesoderm

Plastic and Reconstructive Surgery

Volumn 120, Issue 7, 2007, Pages 1783-1795

  Xu, Yue ^a   Malladi, Preeti ^a   Zhou, Dimin ^a   Longaker, Michael T ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; CADHERIN; CELL ADHESION MOLECULE; COLLAGEN TYPE 1; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 18; FIBROBLAST GROWTH FACTOR RECEPTOR 2; OSTEOPONTIN; UNCLASSIFIED DRUG; WNT5A PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CALVARIA; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOLOGY; EMBRYO DEVELOPMENT; FRONTAL BONE; MESODERM; MOUSE; NEURAL CREST; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SKULL; TISSUE SPECIFICITY;

ALKALINE PHOSPHATASE; ANIMALS; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CELL SEPARATION; CELLS, CULTURED; FRONTAL BONE; GENE EXPRESSION PROFILING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESODERM; MICE; NEURAL CREST; ORGAN SPECIFICITY; OSTEOBLASTS; OSTEOGENESIS; PARIETAL BONE; RECEPTORS, GROWTH FACTOR; WNT PROTEINS;

EID: 37349072150     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000279491.48283.51     Document Type: Article

References (33)

1. Jiang, X., Iseki, S., Maxson, R. E., et al. Tissue origins and interactions in the mammalian skull vault. Dev. Biol. 241: 106, 2002.
2. Cowan, C. M., Quarto, N., Warren, S. M., et al. Age-related changes in the biomolecular mechanisms of calvarial osteoblast biology affect FGF-2 signaling and osteogenesis. J. Biol. Chem. 278: 32005, 2003.
3. Sirola, K. Regeneration of defects in the calvaria. Ann. Med. Exp. Biol. Fenn. 38 (Suppl. 2): 1, 1960.
4. Hassler, W., and Zentner, J. Radical osteoclastic craniectomy in sagittal synostosis. Neurosurgery 27: 539, 1990.
5. Greenwald, J. A., Mehrara, B. J., Spector, J. A., et al. Biomolecular mechanisms of calvarial bone induction: Immature versus mature dura mater. Plast. Reconstr. Surg. 105: 1382, 2000.
6. Greenwald, J. A., Mehrara, B. J., Spector, J. A., et al. Immature versus mature dura mater: II. Differential expression of genes important to calvarial reossification. Plast. Reconstr. Surg. 106: 630, 2000.
7. Greenwald, J. A., Mehrara, B. J., Spector, J. A., et al. Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: Implications for suture fusion and patency. J. Bone Miner. Res. 15: 2413, 2000.
8. Mehrara, B. J., Most, D., Chang, J., et al. Basic fibroblast growth factor and transforming growth factor beta-1 expression in the developing dura mater correlates with calvarial bone formation. Plast. Reconstr. Surg. 104: 435, 1999.
9. Shimoaka, T., Ogasawara, T., Yonamine, A., et al. Regulation of osteoblast, chondrocyte, and osteoclast functions by fibroblast growth factor (FGF)-18 in comparison with FGF-2 and FGF-10. J. Biol. Chem. 277: 7493, 2002.
10. Nugent, M. A., and Iozzo, R. V. Fibroblast growth factor-2. Int. J. Biochem. Cell Biol. 32: 115, 2000.
11. Ornitz, D. M., and Itoh, N. Fibroblast growth factors. Genome Biol. 2: REVIEWS3005, 2001.
12. Ornitz, D. M., and Marie, P. J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16: 1446, 2002.
13. Hajihosseini, M. K., Lalioti, M. D., Arthaud, S., et al. Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics. Development 131: 325, 2004.
14. Song, H. M., Nacamuli, R. P., Xia, W., et al. High-dose retinoic acid modulates rat calvarial osteoblast biology. J. Cell. Physiol. 202: 255, 2005.
15. Nacamuli, R. P., Song, H. M., Fang, T. D., et al. Quantitative transcriptional analysis of fusing and nonfusing cranial suture complexes in mice. Plast. Reconstr. Surg. 114: 1818, 2004.
16. Jorgensen, N. R., Henriksen, Z., Sorensen, O. H., et al. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: Validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 69: 219, 2004.
17. Christakos, S., Dhawan, P., Liu, Y., et al. New insights into the mechanisms of vitamin D action. J. Cell. Biochem. 88: 695, 2003.
18. Hadjiargyrou, M., Lombardo, F., Zhao, S., et al. Transcriptional profiling of bone regeneration: Insight into the molecular complexity of wound repair. J. Biol. Chem. 277: 30177, 2002.
19. Iseki, S., Wilkie, A. O., Heath, J. K., et al. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development 124: 3375, 1997.
20. Ebara, S., and Nakayama, K. Mechanism for the action of bone morphogenetic proteins and regulation of their activity. Spine 27: S10, 2002.
21. Kim, H. J., Rice, D. P., Kettunen, P. J., et al. FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 125: 1241, 1998.
22. Nakamura, Y., Wakitani, S., Nakayama, J., et al. Temporal and spatial expression profiles of BMP receptors and noggin during BMP-2-induced ectopic bone formation. J. Bone Miner. Res. 18: 1854, 2003.
23. Warren, S. M., Brunet, L. J., Harland, R. M., et al. The BMP antagonist noggin regulates cranial suture fusion. Nature 422: 625, 2003.
24. Fong, K. D., Nacamuli, R. P., Song, H. M., et al. New strategies for craniofacial repair and replacement: A brief review. J. Craniofac. Surg. 14: 333, 2003.
25. Wilkie, A. O., Patey, S. J., Kan, S. H., et al. FGFs, their receptors, and human limb malformations: Clinical and molecular correlations. Am. J. Med. Genet. 112: 266, 2002.
26. Ohbayashi, N., Shibayama, M., Kurotaki, Y., et al. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 16: 870, 2002.
27. Wodarz, A., and Nusse, R. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14: 59, 1998.
28. Yamaguchi, T. P., Bradley, A., McMahon, A. P., et al. A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 126: 1211, 1999.
29. Nakayama, K., Tamura, Y., Suzawa, M., et al. Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cells. J. Bone Miner. Res. 18: 827, 2003.
30. Halvorsen, Y. D., Franklin, D., Bond, A. L., et al. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng. 7: 729, 2001.
31. McBeath, R., Pirone, D. M., Nelson, C. M., et al. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev. Cell. 6: 483, 2004.
32. Devlin, R. D., Du, Z., Pereira, R. C., et al. Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology 144: 1972, 2003.
33. Wu, X. B., Li, Y., Schneider, A., et al. Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J. Clin. Invest. 112: 924, 2003.